Form 10-Q TREACE MEDICAL CONCEPTS, For: Mar 31
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/2/2026
- Equities rebound to close higher as surging Treasury yields recede
- Fed’s Jefferson sees no urgency for another rate increase
- Oil jumps 4% on reports China halts fuel exports, US troops head to Middle East
- Amazon and these four U.S. stocks are latest additions to Goldman’s flagship list
- Anthropic targets mid-November for public debut - report
- DataMeds AI's Corexa Pharmacy tops $1M in monthly revenue
- Equities rebound to close higher as surging Treasury yields recede
- Twilio, Vylor set to join S&P 500 as index reshuffles members
- onsemi cuts Synaptics deal price to $5.7B after rival bid
- Wells Fargo names 13 stocks as overweight tactical ideas
Morgan Stanley Downgrades Treace Medical Concepts Inc (TMCI) to Equalweight
May 8, 2024 9:30 AM EDTMorgan Stanley analyst Drew Ranieri downgraded Treace Medical Concepts Inc (NASDAQ: TMCI) from Overweight to Equalweight with a price target of $5.50 (from $15.00).
The analyst comments "Competitive disruptions are hitting Treace's commercial momentum with the company now playing innovation catch up, lowering our... More
Truist Securities Downgrades Treace Medical Concepts Inc (TMCI) to Hold
May 8, 2024 6:45 AM EDTTruist Securities analyst Richard Newitter downgraded Treace Medical Concepts Inc (NASDAQ: TMCI) from Buy to Hold with a price target of $7.00 (from $17.00).
The analyst comments "We downgrade TMCI to Hold from Buy on a reduced growth outlook & projected deceleration trend in 2Q24/2024 due... More
Stifel Downgrades Treace Medical Concepts Inc (TMCI) to Hold
May 8, 2024 6:03 AM EDTStifel analyst Rick Wise downgraded Treace Medical Concepts Inc (NASDAQ: TMCI) from Buy to Hold with a price target of $6.00 (from $15.00).
The analyst comments "We are downgrading TMCI to Hold and lowering our price target to $6 from $15, as multiple increasing competitive headwinds have added incremental... More
BTIG Downgrades Treace Medical Concepts Inc (TMCI) to Neutral
May 8, 2024 5:26 AM EDTBTIG analyst Ryan Zimmerman downgraded Treace Medical Concepts Inc (NASDAQ: TMCI) from Buy to Neutral.
The analyst comments "We are downgrading TMCI shares to Neutral and removing our PT following TMCI's 1Q24 results. Quarterly results were fine as TMCI reported rev. of $51.1M (21.1% Y/Y), above BTIG/Consensus est. of $49.1M/$49.1M as a seasonally strong 4Q extended into the early part of the year. However, increasing pressure from competitors offering osteotomy-specific... More
JPMorgan Downgrades Treace Medical Concepts Inc (TMCI) to Neutral
May 8, 2024 5:01 AM EDTJPMorgan analyst Robbie Marcus downgraded Treace Medical Concepts Inc (NASDAQ: TMCI) from Overweight to Neutral with a price target of $8.00 (from $15.00).
The analyst comments "Treace reported a disappointing update after the close on Tuesday as a good quarter came alongside a significant cut to guidance due to growing competitive headwinds. Starting with the quarter, sales of $51.1M (+21%) came... More
